Participant flow

Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma · Source last updated 2020-03-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Panobinostat was given 20 mg hard gelatin capsules . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV)injection. Dexamethasone was given as an oral dose of 20 mg/day.

   id

   FG000

   title

   Panobinostat + Bortezomib

2. description

   Placebo was given as a hard gelatin capsule in the image of Panobinostat . Bortezomib was given at 1.3 mg/m2 as a 3 to 5 second bolus intravenous (IV) injection. Dexamethasone was given as an oral dose of 20 mg/day.

   id

   FG001

   title

   Placebo + Bortezomib

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         8

      type

      Abnormal test proceedure results

   2. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         1

      type

      Administrative problems

   3. reasons

      1. group Id

         FG000

         num Subjects

         130

      2. group Id

         FG001

         num Subjects

         66

      type

      Adverse Event

   4. reasons

      1. group Id

         FG000

         num Subjects

         21

      2. group Id

         FG001

         num Subjects

         17

      type

      Death

   5. reasons

      1. group Id

         FG000

         num Subjects

         82

      2. group Id

         FG001

         num Subjects

         153

      type

      Disease progression

   6. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         7

      type

      New Cancer therapy

   7. reasons

      1. group Id

         FG000

         num Subjects

         3

      2. group Id

         FG001

         num Subjects

         4

      type

      Protocol Violation

   8. reasons

      1. group Id

         FG000

         num Subjects

         5

      2. group Id

         FG001

         num Subjects

         5

      type

      Untreated

   9. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         0

      type

      Lost to Follow-up

   10. reasons

       1. group Id

          FG000

          num Subjects

          34

       2. group Id

          FG001

          num Subjects

          18

       type

       Withdrawal by Subject

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         387

      2. group Id

         FG001

         num Subjects

         381

      type

      STARTED

   2. achievements

      1. comment

         completed all planned cycles of study treatment as per protocol

         group Id

         FG000

         num Subjects

         102

      2. comment

         completed all planned cycles of study treatment as per protocol

         group Id

         FG001

         num Subjects

         102

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         285

      2. group Id

         FG001

         num Subjects

         279

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice